XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike Kapul who wrote (5219)	12/31/1997 5:34:00 PM
From: Robert K.	Read Replies (2) of 17367

As I said before 130/205 may not be carved in stone. As I understand it the fda wants patients with high glasgow scores and the uk-fda wants all included(not just the sickest). Anything is now possible. We may get a review before, at or above 130. Information is not guaranteed. Never is. BTW-I think liver trial has closed early and is in results phase. bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next